Skip to main content

Day: July 2, 2024

Ascom and Almaviva sign a strategic collaboration agreement for the digitalization of care delivery in Italy with Digistat

Baar, Switzerland, 2 July 2024 Ascom and Almaviva, an Italian leading information and communication technology company, have entered a strategic partnership to drive the digital transformation of the Italian healthcare sector. As part of this partnership, Ascom has been commissioned with significant Digistat projects for patient data management, including professional services and software. Further projects are planned for 2024 and 2025. Ascom and Almaviva, the third largest privately-owned ICT group in Italy, have pooled their expertise and resources in various projects to deploy Digistat solutions across various healthcare facilities in Italy. This state-of-the-art project seeks to advance digitalization in healthcare delivery and accelerate patient data management processes, significantly improving outcomes for patients and healthcare...

Continue reading

Sodexo Q3 Fiscal 2024: continued robust growth, in line with expectations

Issy-les-Moulineaux, July 2, 2024 (7am)Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY) Sodexo Q3 Fiscal 2024: continued robust growth, in line with expectationsOrganic Revenue growth of +6.8%, or +7.2% excluding accounting change Fiscal 2024 guidance confirmed:Organic growth at the top of the +6% to +8% range Underlying operating profit margin improvement of +30 to +40 bps, at constant currenciesQ3 FISCAL 2024 REVENUESREVENUES(in million euros) Q3 FY24 Q3 FY23   ORGANICGROWTH EXTERNALGROWTH CURRENCYEFFECT TOTALGROWTHNorth America               2,904                2,658    +9.0 % -0.4 % +0.6 % +9.2 %Europe               2,096                2,042    +5.4 % -2.7 % — % +2.7 %Rest of the World               1,074                1,055    +3.6 % +0.6 % -2.3 % +1.9 %SODEXO              6,074               5,755    ...

Continue reading

Equinor ASA: Completed share capital reduction

On 14 May 2024, the annual general meeting in Equinor ASA (OSE: EQNR, NYSE: EQNR) decided that the company’s share capital shall be reduced by NOK 525,808,437.50 from NOK 7,507,761,512.50 to NOK 6,981,953,075.00, through cancellation and redemption of a total of 210,323,375 shares. The creditor deadline for the capital reduction has expired and the capital reduction was registered effective with the Norwegian Register of Business Enterprises today, 2 July 2024. Following completion of the capital reduction the share capital of the company is NOK 6,981,953,075.00 divided into 2,792,781,230 shares. Contact persons: Investor relations:Bård Glad Pedersen, senior vice president,+47 918 01 791 Media relations:Sissel Rinde, vice president,+47 412 60 584 This information is subject to the disclosure requirements pursuant to Section 5-12 of the...

Continue reading

RF Acquisition Corp II Announces the Separate Trading of its Ordinary Shares and Rights Commencing July 5, 2024

GRAND CAYMAN, Cayman Islands, July 01, 2024 (GLOBE NEWSWIRE) — RF Acquisition Corp II (NASDAQ: RFAIU) (the “Company”) announced that, commencing July 5, 2024, holders of the 11,500,000 units sold in the Company’s initial public offering may elect to separately trade the ordinary shares and rights included in the units. Any units not separated will continue to trade on The Nasdaq Global Market (the “Nasdaq”) under the symbol “RFAIU,” and the separated ordinary shares and rights are expected to trade on the Nasdaq under the symbols “RFAI” and “RFAIR,” respectively. Unitholders will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into ordinary shares and rights. The units were initially offered by the Company in an underwritten offering....

Continue reading

Announcement from Liqueous LP on Canna-Global Transactions

DOVER, Del., July 01, 2024 (GLOBE NEWSWIRE) — Liqueous LP announced today that it is working with Canna-Global Acquisition Corp. (NASDAQ: CNGL) to address Canna-Global’s invalid issuance of Class A common stock to Liqueous LP. When Liqueous acquired the shares, Canna-Global represented in writing that the shares were duly and validly issued, and Liqueous relied on those representations, which Liqueous now understands may be inaccurate. Liqueous intended to acquire the Canna-Global shares in exchange for the extinguishment of certain debts of Canna-Global, which Liqueous acquired from third parties with the consent of Canna-Global. The extinguishment of such debt provided substantial financial benefits to Canna-Global and its stockholders. Liqueous intends to continue to work diligently with all relevant parties to resolve the matter. Liqueous...

Continue reading

Advanced MedTech Announces Leadership Transition & Reports Record Revenues for FY2024

WONG Yau Chung appointed Group CEO of Advanced MedTechWONG Yau Chung appointed Group CEO of Advanced MedTechSingapore, July 02, 2024 (GLOBE NEWSWIRE) —Abel Ang retires as Group Chief Executive Officer after a decade and will continue to serve on the Board of Directors Achieved record global revenues of US$335.0 million, a 15.1% increase year-over-year driven by strong performances in all segments United States entities grew revenue by 22.3%, making up 55.4% of total revenue and 65.3% of urology revenue Continued commitment in innovation with R&D investment increasing 20.8% year-over-yearSINGAPORE, 2 July 2024 – Advanced MedTech Holdings (AMTH or the Group), innovative global leader in urology, announced that Abel Ang will retire as Group Chief Executive Officer (CEO) as part of a planned leadership transition....

Continue reading

The first JAPAN IR Event 2024 was held at Nasdaq’s U.S. headquarters

Four Nasdaq-listed Japanese Companies Gather to Showcase the Appeal of Japanese Companies to the World TOKYO, July 01, 2024 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“Medirom” or the “Company”), a holistic healthcare company based in Japan, announced that on June 20th the Company was one of four Nasdaq listed Japanese companies that presented at the NASDAQ JAPAN IR EVENT 2024 at Nasdaq’s U.S. headquarters. The Nasdaq event aimed to increase the presence of Japanese companies in the U.S. Four Japanese companies listed on Nasdaq presented to over 120 investors and media. Joseph Brantuk, Global Listings Chief Client Officer of NASDAQ.“This is an excellent initiative to bring the appeal of Japanese companies directly to investors. To continue attracting attention and increasing communication...

Continue reading

WTW announces leadership change in Australia and New Zealand to foster continued growth

James Baum is appointed as Head of Australia and New Zealand and Head of Corporate Risk & Broking Australia and New Zealand SYDNEY, July 01, 2024 (GLOBE NEWSWIRE) — WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company, today announced the appointment of James Baum as WTW Head of Australia and New Zealand, and Head of Corporate Risk & Broking (CRB) Australia and New Zealand, effective 15 July. Simon Weaver will continue to serve as WTW Head of Asia Pacific and Head of CRB for Asia Pacific. Pamela Thomson-Hall, WTW Head of International and Head of Risk & Broking International, commented, “I am delighted to have someone of James’s calibre join WTW. This appointment speaks to the company’s ability to attract market-leading talent. James is a seasoned leader with over 30 years of experience and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.